AspirinforthePreventionofCardiovascularEvents in Patients With Peripheral Artery Disease

Context Randomized trials have shown that aspirin decreases the risk of cardiovascular events in patients with symptomatic coronary and cerebrovascular disease. Despite guideline recommendations for secondary prevention in peripheral artery disease (PAD), the effect of aspirin in this population is not well established. Objective To investigate the effect of aspirin on cardiovascular event rates in patients with PAD.